BALY
Bally's Corporation
BALY has slightly lower modeled downside risk, despite its lower overall score.
LCID
Lucid Group, Inc.
LCID has the edge over BALY overall, supported by stronger fundamentals and stronger modeled upside.
BALY Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Weak |
BALY's revenue is currently strong, but its profitability, cash flow and balance sheet are under pressure.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
BALY PE Valuation
BALY has no meaningful PE right now: it lost money over the past year.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
BALY Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect BALY's losses to grow, with revenue growing.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
BALY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$12.64 | -$2.59 |
| Q1 2026 | -$13.99 | -$6.46 |
| Q4 2025 | -$10.73 | +$0.98 |
| Q3 2025 | -$6.65 | +$8.42 |
| Q2 2025 | -$10.05 | +$1.07 |
| Q1 2025 | -$7.53 | +$2.83 |
| Q4 2024 | -$11.71 | -$8.20 |
| Q3 2024 | -$15.07 | -$8.34 |
BALY is still losing money, but less than at its worst: $12.64 per share over the past year, against $15.07 at its worst in late 2024.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID has the edge over BALY on earnings, with more consistent year-over-year improvement.
BALY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $792.2M | +20% |
| Q1 2026 | $755.7M | +105% |
| Q4 2025 | $746.2M | +29% |
| Q3 2025 | $663.7M | +5.4% |
| Q2 2025 | $657.5M | +5.8% |
| Q1 2025 | $368.7M | -40% |
| Q4 2024 | $580.4M | -5.1% |
| Q3 2024 | $630M | -0.4% |
BALY's revenue has grown year over year for five quarters in a row: $792M last quarter, up 20% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -4.3% | -3.9 points |
| Q1 2026 | 12% | +13 points |
| Q4 2025 | -37% | -31 points |
| Q3 2025 | 0.1% | +25 points |
| Q2 2025 | -0.4% | -1.3 points |
| Q1 2025 | -0.5% | +12 points |
| Q4 2024 | -5.6% | +46 points |
| Q3 2024 | -25% | -31 points |
BALY has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over BALY on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
BALY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$156M | -$123.8M |
| Q1 2026 | -$183.9M | -1693% |
| Q4 2025 | -$18.9M | -$12.7M |
| Q3 2025 | -$139.3M | -$83.5M |
| Q2 2025 | -$32.2M | -372% |
| Q1 2025 | $11.5M | +$47.5M |
| Q4 2024 | -$6.2M | -125% |
| Q3 2024 | -$55.8M | +$36.5M |
BALY has the edge over LCID on cash flow, with more consistent year-over-year improvement.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
BALY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +340K shares |
| 1 year | -0.2% | -98K shares |
| 3 years | +10% | +5.5M shares |
| 5 years | +69% | +24.8M shares |
| Available history | +60% | +22.7M shares |
BALY has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $416.2M |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
BALY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 28.0x | High |
| Q1 2026 | 24.2x | High |
| Q4 2025 | 240.2x | High |
| Q3 2025 | 15.9x | High |
| Q2 2025 | 51.6x | High |
| Q1 2025 | 40.0x | High |
| Q4 2024 | 26.0x | High |
| Q2 2024 | 39.9x | High |
BALY's net debt is more than 20 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BALY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.9 | Neutral |
| Stochastic | 65.0 | Neutral |
BALY's weekly RSI is 45 (neutral) and its Stochastic is 65 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
BALY PE vs Consumer Cyclical Sector
| Metric | BALY | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
BALY has no meaningful PE right now: it lost money over the past year.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
BALY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 13% below |
| 20 week MA | $12.6 | 8.2% below |
| 50 week MA | $13.5 | 15% below |
| 100 week MA | $13.6 | 15% below |
| 200 week MA | $14.2 | 19% below |
BALY is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
BALY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $25.9 | $48.8 | +88% |
| 2021 | $48.8 | $37.5 | -23% |
| 2022 | $37.5 | $19.4 | -48% |
| 2023 | $19.4 | $13.9 | -28% |
| 2024 | $13.9 | $17.8 | +28% |
| 2025 | $17.8 | $17.8 | -0.4% |
| 2026 YTD | $17.8 | $11.5 | -35% |
BALY has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.